Followers | 19 |
Posts | 1929 |
Boards Moderated | 0 |
Alias Born | 07/30/2012 |
Monday, August 20, 2018 1:03:26 PM
https://scbiznews.com/news/government/44688/
Regulatory approval
Dr. Robert M. Sade, director of the Institute of Human Values in Health Care and professor of surgery at the Medical University of South Carolina, said “there are ethics questions involved.” Those questions, he said, should be directed as much to the FDA as to any medical company taking the medical care offshore.
“The FDA has produced a system that retards the introduction of effective new treatments,” Sade said. “It takes a billion dollars and 10 years to put a new product on the market because of the demands of the FDA for multiple studies, for all kinds of information that I believe is largely unnecessary.”
He said physicians who are involved in providing such offshore medical treatments are “ethically bound not to use treatments that have no basis in science. There are people who take treatments offshore because they are quacks.”
Sade said “if there is scientific evidence the treatment is effective but still hasn’t been approved by the FDA, it would not be unethical to take it offshore.”
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM